Judson Taylor
Director Técnico/Científico/I+D en DIANTHUS THERAPEUTICS, INC. .
Perfil
Judson Taylor's current job is as the Head-Technical Operations at Dianthus Therapeutics, Inc. Mr. Taylor's former jobs include being the Vice President-Technical Operations at Radius Health, Inc. from 2018 to 2022, and the Vice President-Supply Chain at Synergy Pharmaceuticals LLC from 2015 to 2018.
Mr. Taylor's education includes an MBA degree from Temple University (Pennsylvania) and an undergraduate degree from The Pennsylvania State University.
Cargos activos de Judson Taylor
| Empresas | Cargo | Inicio |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 11/09/2023 |
Antiguos cargos conocidos de Judson Taylor.
| Empresas | Cargo | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Director Técnico/Científico/I+D | 01/05/2022 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01/08/2018 |
Formación de Judson Taylor.
| Temple University (Pennsylvania) | Masters Business Admin |
| The Pennsylvania State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Judson Taylor